Follow @TheHPRA
Contact us
As Gaeilge
My HPRA:
Login
Register
About Us
Medicines
Veterinary
Medical Devices
Cosmetics
Controlled Substances
Blood, Tissues, Organs
Medicines
Safety Notices
My HPRA:
Login
Register
About Us
Medicines
COVID-19 vaccines and treatments
Our Role
Medicines Information
Safety Information
Safety Notices
Quality Information
Regulatory Information
News & Events
Special Topics
Emergency Medicines
Emergency Contact Details
Veterinary
Medical Devices
Cosmetics
Controlled Substances
Blood, Tissues, Organs
Levemir FlexPen & NovoRapid FlexPen - Important Safety Information from Novo Nordisk following approval by the Irish Medicines Board
Notice type:
Advisory
Date:
02/02/2009
Problem Or Issue:
Please find attached safety information communication from Novo Nordisk regarding the importance of highlighting the differences between these products to patients administering them as part of the treatment of diabetes.
Important Safety Information-Levemir FlexPen and NovoRapid FlexPen
« Back
Date Printed: 29/03/2024